ClinicalTrials.gg
Drug

4-Aminopyridine clinical trials

Also written Ampyra, Dalfampridine, Fampyra and BIIB041.

studies test it
61
open now
12
in phase 3
20
first study started
2002

How each study uses 4-Aminopyridine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the 4-Aminopyridine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Jan 2010 · AMPYRA · NDA 022250 (FDA, Drugs@FDA)
European Union
20 Jul 2011 · Fampyra · EMEA/H/C/002097 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

4-Aminopyridine
17
Fampridine-SR
7
Fampridine SR
6
4-aminopyridine (4-AP)
3
fampridine prolonged-release tablets
2

Brand

Ampyra
20
Fampyra
11
4AP
3

Development codes

BIIB041
2

Other names

Dalfampridine
20
Fampridine
7
4-AP
5
Dalfampridine 10 MG
1

Studies by the year they started

59 studies that test it; most in 2014 (8); 1 more planned to start later

Studies that test 4-Aminopyridine, by start year
YearStudies
20023
20032
20051
20061
20072
20103
20112
20126
20134
20148
20152
20162
20182
20192
20201
20214
20223
20241
20255
20265

Who runs them

Industry 16 · Other 45

Acorda Therapeutics (10) · Biogen (6) · John Elfar (4) · Prof. Dominique de Quervain, MD (3) · University of Southern Denmark (3) · Shirley Ryan AbilityLab (2) · Coordinación de Investigación en Salud, Mexico (2) · Milton S. Hershey Medical Center (2)

Often tested with

Tested in the same studies.

Imatinib (1) · Atenolol (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 3 in phase 3

Studies that test 4-Aminopyridine, phase 3 first.

Studies

Open first, then newest update. How each study uses 4-Aminopyridine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 61

See all 61 studies that test 4-Aminopyridine →

Codes

What other systems call 4-Aminopyridine · ClinicalTrials.gg INT008495

  • MeSH (NLM) D0157614-AminopyridineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) BH3B64OKL9DALFAMPRIDINEConfirmed FDA, NLM
  • RxNorm 897018One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.